TY - JOUR
T1 - Electrical storm in patients with Brugada syndrome is associated with early repolarization
AU - Kaneko, Yoshiaki
AU - Horie, Minoru
AU - Niwano, Shinichi
AU - Kusano, Kengo F.
AU - Takatsuki, Seiji
AU - Kurita, Takashi
AU - Mitsuhashi, Takeshi
AU - Nakajima, Tadashi
AU - Irie, Tadanobu
AU - Hasegawa, Kanae
AU - Noda, Takashi
AU - Kamakura, Shiro
AU - Aizawa, Yoshiyasu
AU - Yasuoka, Ryobun
AU - Torigoe, Katsumi
AU - Suzuki, Hiroshi
AU - Ohe, Toru
AU - Shimizu, Akihiko
AU - Fukuda, Keiichi
AU - Kurabayashi, Masahiko
AU - Aizawa, Yoshifusa
N1 - Publisher Copyright:
© 2014 American Heart Association, Inc.
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Background: Electrical storms (ESs) in patients with Brugada syndrome (BrS) are rare though potentially lethal. Methods and Results: We studied 22 men with BrS and ES, defined as ≥3 episodes/d of ventricular fibrillation (VF) and compared their characteristics with those of 110 age-matched, control men with BrS without ES. BrS was diagnosed by a spontaneous or drug-induced type 1 pattern on the ECG in the absence of structural heart disease. Early repolarization (ER) was diagnosed by J waves, ie, >0.1 mV notches or slurs of the terminal portion of the QRS complex. The BrS ECG pattern was provoked with pilsicainide. A spontaneous type I ECG pattern, J waves, and horizontal/descending ST elevation were found, respectively, in 77%, 36%, and 88% of patients with ES, versus 28% (P<0.0001), 9% (P=0.003), and 60% (P=0.06) of controls. The J-wave amplitude was significantly higher in patients with than without ES (P=0.03). VF occurred during undisturbed sinus rhythm in 14 of 19 patients (74%), and ES were controlled by isoproterenol administration. All patients with ES received an implantable cardioverter defibrillator and over a 6.0±5.4 years followup, the prognosis of patients with ES was significantly worse than that of patients without ES. Bepridil was effective in preventing VF in 6 patients. Conclusions: A high prevalence of ER was found in a subgroup of patients with BrS associated with ES. ES appeared to be suppressed by isoproterenol or quinidine, whereas bepridil and quinidine were effective in the long-term prevention of VF in the highest-risk patients.
AB - Background: Electrical storms (ESs) in patients with Brugada syndrome (BrS) are rare though potentially lethal. Methods and Results: We studied 22 men with BrS and ES, defined as ≥3 episodes/d of ventricular fibrillation (VF) and compared their characteristics with those of 110 age-matched, control men with BrS without ES. BrS was diagnosed by a spontaneous or drug-induced type 1 pattern on the ECG in the absence of structural heart disease. Early repolarization (ER) was diagnosed by J waves, ie, >0.1 mV notches or slurs of the terminal portion of the QRS complex. The BrS ECG pattern was provoked with pilsicainide. A spontaneous type I ECG pattern, J waves, and horizontal/descending ST elevation were found, respectively, in 77%, 36%, and 88% of patients with ES, versus 28% (P<0.0001), 9% (P=0.003), and 60% (P=0.06) of controls. The J-wave amplitude was significantly higher in patients with than without ES (P=0.03). VF occurred during undisturbed sinus rhythm in 14 of 19 patients (74%), and ES were controlled by isoproterenol administration. All patients with ES received an implantable cardioverter defibrillator and over a 6.0±5.4 years followup, the prognosis of patients with ES was significantly worse than that of patients without ES. Bepridil was effective in preventing VF in 6 patients. Conclusions: A high prevalence of ER was found in a subgroup of patients with BrS associated with ES. ES appeared to be suppressed by isoproterenol or quinidine, whereas bepridil and quinidine were effective in the long-term prevention of VF in the highest-risk patients.
KW - Bepridil
KW - Brugada syndrome
KW - Electrocardiography
KW - Isoproterenol
KW - Ventricular fibrillation
UR - http://www.scopus.com/inward/record.url?scp=84925547749&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925547749&partnerID=8YFLogxK
U2 - 10.1161/CIRCEP.114.001806
DO - 10.1161/CIRCEP.114.001806
M3 - Article
C2 - 25221333
AN - SCOPUS:84925547749
SN - 1941-3149
VL - 7
SP - 1122
EP - 1128
JO - Circulation: Arrhythmia and Electrophysiology
JF - Circulation: Arrhythmia and Electrophysiology
IS - 6
ER -